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A quantitative analysis of relationships between structures of  l-[(2-hydroxyethoxy)methyl]-
5-benzyluracils and efficiency of inhibition of the catalytic activity of murine liver uridine 
phosphorylase (UrdPase) was made by the program GUSAR 2013 (General Unrestricted Structure 
Activity Relationships) [1-2]. Biological data from ChEMBL [3] were used for creation of QSAR 
models. In general 50 statistically significant QSAR-models (Rtrain set
2
> 0.6, Rtest set
2
> 0.5, Q
2
> 0.6) 
for prediction of IC50 values for various l-[(2-hydroxyethoxy)methyl]-5-benzyluracils against murine 
liver UrdPase were created based on MNA- and QNA-descriptors, as well as consensus of their 
combinations. The statistical characteristics of some of the models we constructed are presented in 
the Table1. Training set TrS2 and test set TS included 48 and 16 structures of UrdPase inhibitors, 
respectively. They were obtained by dividing the pre- sorted in ascending order of IC50 values in 
ratio 3:1, i.e. excluded from TrS1 every fourth compound to UrdPase.  These models can be used for 
quantitative prediction of potential anti-tumor drugs against UrdPase. Atoms and structural 
fragments of the studied structures influencing on increase and decrease of UrdPase  inhibition were 
identified by GUSAR 2013 visualization of quantitative “structure-activity” relationships in the 
created models. The results of structural analysis of the contribution of the different functional 
groups in the activity of UrdPase  inhibition can be considered in the molecular design of active 
substances of known anticancer drugs in order to enhance the efficiency of their inhibitory action 
UrdPase.  
Table 1. Characteristics and prediction accuracy of IC50 values for consensus models  
M1 - M6. pIC50 activity in TrS1 and TrS2 lies in the range -5.111 ‒ -1.431. 
Training set Models N R
2
ОВ R
2
ТВ F S.D. Q
2
 V 
QSAR model based on MNA-descriptors 
TSet1 М1 48 0.899 - 29.462 0.349 0.871 8 
TSet2 М2 36 0.924 0.763 25.155 0.319 0.893 8 
QSAR model based on QNA-descriptors 
TSet1 М3 48 0.868 - 17.193 0.413 0.820 9 
TSet2 М4 36 0.917 0.611 18.466 0.351 0.870 9 
QSAR model based on MNA- and QNA-descriptors 
TSet1 М5 48 0.884 - 26.892 0.374 0.852 8 
TSet2 М6 36 0.919 0.778 21.647 0.338 0.880 8 
N – number of structures in the training set; R2TrS - a multiple coefficient of determination calculated 
for compounds from the training set; R
2
TS - a multiple coefficient of determination calculated for 
compounds from the test set; Q
2
 – a cross-validated R2 calculated during leave-one-out cross-
validation procedure on data of the training set; F – Fisher's coefficient; SD – standard deviation; V- 
the number of variables in the final regression equation. 
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